Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease

Anti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases...

Full description

Bibliographic Details
Main Authors: Yu Song, Shanshan Chen, Ju Gao, Jie Lu, Wenwen Xu, Xingjian Lin, Jiu Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/full
id doaj-19490111966d46548de786b754a0bcc7
record_format Article
spelling doaj-19490111966d46548de786b754a0bcc72021-07-02T05:25:57ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-07-011210.3389/fneur.2021.673347673347Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's DiseaseYu Song0Shanshan Chen1Ju Gao2Jie Lu3Wenwen Xu4Xingjian Lin5Jiu Chen6Jiu Chen7Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Geriatric Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaInstitute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, ChinaInstitute of Brain Functional Imaging, Nanjing Medical University, Nanjing, ChinaAnti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases, such as malignancy, has revealed the possibility of potential copathogenesis. However, there have not yet been reports about anti-AMPAR encephalitis with concomitant cerebrospinal fluid (CSF) biomarkers consistent with Alzheimer disease (AD). Herein, we present the case of an elderly male patient with autoimmune encephalitis (AE) presenting with anti–AMPA1-R and anti–AMPA2-R antibodies, as well as CSF biomarkers of AD. The patient was hospitalized with acute memory decline for 1 week. Anti–AMPA1-R and anti–AMPA2-R antibodies were positively detected in CSF, and the anti–AMPA2-R antibody was also present in the serum. Additionally, the biomarkers of AD were concurrently present in CSF (Aβ1−42 = 245.70 pg/mL, t-Tau = 894.48 pg/mL, p-Tau = 78.66 pg/mL). After administering a combined treatment of intravenous immunoglobulin and glucocorticoids, the patient recovered significantly, and his cognitive function achieved a sustained remission during 2 months' follow-up. This case raises the awareness of a possible interaction between AE and changes of CSF biomarkers. We speculated that the existence of AMPAR antibodies can induce changes of CSF, and other pathological alterations. This present report highlights that a potential relationship exists among AE and provides a warning when making the diagnosis of AD.https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/fullautoimmune encephalitisanti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptorAlzheimer's diseasecognitive impairmentcerebrospinal fluid biomarkers
collection DOAJ
language English
format Article
sources DOAJ
author Yu Song
Shanshan Chen
Ju Gao
Jie Lu
Wenwen Xu
Xingjian Lin
Jiu Chen
Jiu Chen
spellingShingle Yu Song
Shanshan Chen
Ju Gao
Jie Lu
Wenwen Xu
Xingjian Lin
Jiu Chen
Jiu Chen
Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
Frontiers in Neurology
autoimmune encephalitis
anti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptor
Alzheimer's disease
cognitive impairment
cerebrospinal fluid biomarkers
author_facet Yu Song
Shanshan Chen
Ju Gao
Jie Lu
Wenwen Xu
Xingjian Lin
Jiu Chen
Jiu Chen
author_sort Yu Song
title Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
title_short Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
title_full Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
title_fullStr Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
title_full_unstemmed Case Report: Coexistence of Anti-AMPA Receptor Encephalitis and Positive Biomarkers of Alzheimer's Disease
title_sort case report: coexistence of anti-ampa receptor encephalitis and positive biomarkers of alzheimer's disease
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2021-07-01
description Anti–α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare autoimmune disease that is characterized by acute cognitive impairment, mental symptoms, and seizures. The high comorbidity rate between anti–AMPA receptor (AMPAR) encephalitis and other somatic diseases, such as malignancy, has revealed the possibility of potential copathogenesis. However, there have not yet been reports about anti-AMPAR encephalitis with concomitant cerebrospinal fluid (CSF) biomarkers consistent with Alzheimer disease (AD). Herein, we present the case of an elderly male patient with autoimmune encephalitis (AE) presenting with anti–AMPA1-R and anti–AMPA2-R antibodies, as well as CSF biomarkers of AD. The patient was hospitalized with acute memory decline for 1 week. Anti–AMPA1-R and anti–AMPA2-R antibodies were positively detected in CSF, and the anti–AMPA2-R antibody was also present in the serum. Additionally, the biomarkers of AD were concurrently present in CSF (Aβ1−42 = 245.70 pg/mL, t-Tau = 894.48 pg/mL, p-Tau = 78.66 pg/mL). After administering a combined treatment of intravenous immunoglobulin and glucocorticoids, the patient recovered significantly, and his cognitive function achieved a sustained remission during 2 months' follow-up. This case raises the awareness of a possible interaction between AE and changes of CSF biomarkers. We speculated that the existence of AMPAR antibodies can induce changes of CSF, and other pathological alterations. This present report highlights that a potential relationship exists among AE and provides a warning when making the diagnosis of AD.
topic autoimmune encephalitis
anti-α-amino-3-hydroxy-5-methyl-4-lsoxazolepropionic acid receptor
Alzheimer's disease
cognitive impairment
cerebrospinal fluid biomarkers
url https://www.frontiersin.org/articles/10.3389/fneur.2021.673347/full
work_keys_str_mv AT yusong casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT shanshanchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT jugao casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT jielu casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT wenwenxu casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT xingjianlin casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT jiuchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
AT jiuchen casereportcoexistenceofantiampareceptorencephalitisandpositivebiomarkersofalzheimersdisease
_version_ 1721338580604813312